Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Schnell

Showing results (11-20 of 318) with videos related to

Pageof 32
Sort By:
Journal of Diabetes Science and Technology|August 23, 2018
Health Technology Assessments for Flash Glucose Monitoring and How to Use Them in Everyday Clinical PracticeMagnus Stueve, Oliver Schnell
Journal of Diabetes Science and Technology|June 2, 2020
COVID-19: Considerations of Diabetes and Cardiovascular Disease ManagementAntonio Ceriello, Oliver Schnell
Diabetes & Vascular Disease Research|April 18, 2012
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluationEberhard Standl, Oliver Schnell
Journal of Diabetes Science and Technology|November 4, 2009
Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: a never ending story?Oliver Schnell, Lutz Heinemann
Diabetes Technology & Therapeutics|October 14, 2009
The assessment of glycemic variability and its impact on diabetes-related complications: an overviewChristian Weber, Oliver Schnell
Diabetes Care|February 15, 2008
Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?Eberhard Standl, Oliver Schnell
Journal of Diabetes Science and Technology|May 31, 2014
Impact of a reduced error range of SMBG in insulin-treated patients in GermanyOliver Schnell, Michael Erbach
Journal of Diabetes and Its Complications|February 11, 2012
Diabetes and the risk for colorectal cancerMichael Erbach, Hellmut Mehnert, Oliver Schnell
Best Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
The impact of glucose-lowering therapy on cardiovascular outcomesEberhard Standl, Martin Müller, Oliver Schnell
Cardiology and Therapy|August 20, 2014
Glycemic control: a combination of lifestyle management and the use of drugsEberhard Standl, Michael Erbach, Oliver Schnell
Pageof 32

Showing results (11-20 of 318) with videos related to

Sort By:
Pageof 32
Journal of Diabetes Science and Technology|August 23, 2018
Health Technology Assessments for Flash Glucose Monitoring and How to Use Them in Everyday Clinical PracticeMagnus Stueve, Oliver Schnell
Journal of Diabetes Science and Technology|June 2, 2020
COVID-19: Considerations of Diabetes and Cardiovascular Disease ManagementAntonio Ceriello, Oliver Schnell
Diabetes & Vascular Disease Research|April 18, 2012
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluationEberhard Standl, Oliver Schnell
Journal of Diabetes Science and Technology|November 4, 2009
Self-monitoring of blood glucose in noninsulin-treated patients with type 2 diabetes: a never ending story?Oliver Schnell, Lutz Heinemann
Diabetes Technology & Therapeutics|October 14, 2009
The assessment of glycemic variability and its impact on diabetes-related complications: an overviewChristian Weber, Oliver Schnell
Diabetes Care|February 15, 2008
Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?Eberhard Standl, Oliver Schnell
Journal of Diabetes Science and Technology|May 31, 2014
Impact of a reduced error range of SMBG in insulin-treated patients in GermanyOliver Schnell, Michael Erbach
Journal of Diabetes and Its Complications|February 11, 2012
Diabetes and the risk for colorectal cancerMichael Erbach, Hellmut Mehnert, Oliver Schnell
Best Practice & Research. Clinical Endocrinology & Metabolism|June 13, 2009
The impact of glucose-lowering therapy on cardiovascular outcomesEberhard Standl, Martin Müller, Oliver Schnell
Cardiology and Therapy|August 20, 2014
Glycemic control: a combination of lifestyle management and the use of drugsEberhard Standl, Michael Erbach, Oliver Schnell
Pageof 32